Overview
Muller & Phipps is a healthcare and pharmaceutical importer and distributor with an island-wide network of 16 distributors and more than 3,000 customer touchpoints. Its activities span pharmaceutical distribution, medical engagement, supply chain management and therapeutic nutrition.
The latest quarter showed narrower operating and net losses, but weaker revenue and a sharply lower gross margin mean the business has not yet demonstrated a durable recovery in its core operations.
Price performance
The share gained 4.8% over one year to LKR 2.20 as at 7 August 2026, outperforming the ASPI’s 9.5% decline over the same period. Over three months, however, it fell 4.3% against a 7.1% decline in the index, so the longer-term outperformance has not been consistent.
The price sits around the middle of its 52-week range, at 53.8% of the distance from the low to the high. Recent volatility is below the company’s own one-year level, while trading volume is above its recent norm. The stock’s beta to the ASPI is 3.83, indicating strong co-movement with the index rather than low volatility.
Valuation
Standard earnings and book-based valuation are not meaningful because trailing EPS is negative at LKR 0.252 and book value per share is negative at LKR 0.56. P/E, P/B and ROE are therefore unavailable for a useful comparison with the consumer-retail sector.
The recorded dividend yield is 0.0%, and no dividend history is supplied, so there is no evidence of a recurring payout to offset the operating losses. A sector percentile comparison is also unavailable in the supplied data.
News and sentiment
Company-specific coverage was thin: no material articles were recorded in the 90-day window, with no positive, negative or neutral articles in the supplied news set.
No confirmed or announced corporate actions were provided. The absence of coverage leaves the filings, rather than news sentiment, as the main source of evidence on the company.
Financials
The June 2026 quarter’s gross margin fell to 17.4% from 30.5% a year earlier, while operating margin improved to negative 12.8% from negative 16.6% and net margin improved to negative 17.2% from negative 19.4%. These are like-for-like group-basis comparisons.
Revenue fell year-on-year and both operating and net losses narrowed, but the improvement was not driven by gross-margin strength. Gross margin was the worst of the company’s comparable June quarters, operating margin ranked among the weakest, and net margin was middling within that June record. Finance costs and other below-the-line items remained a drag of LKR 5.7 million in the latest quarter.
For the year ended March 2026, revenue and operating profit were lower than the prior year, while the net loss narrowed. Equity attributable to owners remained negative, and the share count was 283 million, so the negative EPS reflects continuing losses rather than a share-count change.
Risks
The most material risk is the balance sheet: June total debt was LKR 266.6 million against negative owners’ equity of LKR 157.6 million. Annual interest cover was negative at 2.96 times, meaning operating losses did not cover finance costs, while the current ratio was not reported for the latest annual period.
Cash generation is uneven. Annual cash conversion was 1.37 times, but operating cash flow in the June quarter was negative at LKR 85.2 million, weakening confidence that the accounting improvement is translating into cash. The company also operates in a consumer-retail environment where July inflation reached 7.3% and a reported fuel-price increase of around 47% raises transport and household-cost pressure.
Outlook
The next specific test is the group filing for the quarter ending 30 September 2026. As at 8 August 2026, the exchange-based expected filing window runs from 28 October 2026 to 26 January 2027; that release will show whether the June loss narrowing and revenue weakness have continued or reversed.
The wider environment is mixed: interest rates have been easing, but elevated inflation and fuel costs can pressure distribution expenses and customer purchasing power. The current data cannot establish whether the share-price moves were caused by these conditions, and the thin company-specific news flow provides no additional explanation.